Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Covista – America's Largest Healthcare Educator

Covista, formerly known as Adtalem Global Education, has undergone a significant transformation over the past four years to become America's largest healthcare educator. With a focus on healthcare, the company now operates five accredited institutions serving over 97,000 students and 385,000 alumni. Notably, Covista graduates 24,000 healthcare professionals annually, including 10% of America's nurses and twice as many doctors of medicine (MDs) as any MD-granting school in the U.S.

The company's strategic shift towards healthcare has culminated in the release of the "Covista Care Capacity Monitor," a proprietary research platform that provides comprehensive insights into the U.S. healthcare workforce crisis. The findings reveal the magnitude of the shortage, with more than 702,000 healthcare job vacancies posted every month, while only 306,000 unemployed healthcare workers exist to fill them. This shortage is widespread across geographies and healthcare roles, affecting patient care quality and capacity.

Moreover, the company has unveiled a multi-year impact commitment called Covista Open Doors, aimed at inspiring individuals to pursue healthcare careers, supporting students in achieving their healthcare ambitions, and addressing the wellbeing of healthcare workers through mental health and career longevity programs.

Covista will be hosting an investor day on February 24, where it will outline its long-term strategy and growth targets, providing detailed insights on how the company intends to capitalize on the evolving market dynamics in healthcare education and workforce development.

As a result of these announcements, the company's shares have moved -0.46% on the market, and are now trading at a price of $116.85. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS